The Centers for Disease Control and Prevention reports that there has been another death in Maryland from fungal meningitis related to recalled medications.
This year’s flu season is the earliest since 2003-04 and that season was considered severe.
House lawmakers investigating a nationwide outbreak of deadly meningitis have summoned the head of the Food and Drug Administration to testify at the first congressional hearing on the issue next week.
The Centers for Disease Control and Prevention (CDC) has determined that fungus found in tainted steroid shots matches the one behind the national outbreak. At the same time, a major health institution in Maryland has formulated vital information for treatment.
Nearly 43 percent of American kids who died from the flu were perfectly healthy beforehand – and the healthier kids died faster.
The number of cases linked to a meningitis outbreak continues to rise. Nationwide, four more deaths have been reported since just Tuesday, bringing the total to 19, including one Marylander.
The number of meningitis cases linked to steroid injections for back pain continues to grow in Maryland.
Death rates dropped significantly last year for five out of the 15 leading causes of death in the U.S.
Scattered across the carefully landscaped main campus of the Centers for Disease Control and Prevention are the staff on the front lines fighting a rare outbreak of fungal meningitis: A scientist in a white lab coat peers through a microscope at fungi on a glass slide. In another room, another researcher uses what looks like a long, pointed eye dropper to suck up DNA samples that will be tested for the suspect fungus.
Meningitis cases caused by contaminated injections have climbed to 105 nationally with an eighth death confirmed by the Centers for Disease Control.
As of Sunday, the death toll from the meningitis outbreak stands at seven.
A state work group on private laboratories that handle dangerous pathogens is holding its first meeting at the Department of Health and Mental Hygiene in Baltimore.